NCT03258554-D3
Dataset Information
Dataset ID: NCT03258554-D3
PubMed ID (PMID):
Publication Title:
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial
Description of Dataset:
This data submission (NCT03258554-D3) contains the outcome data used to generate the results for the phase II prespecified analysis in PubMed ID = 39551064, a publication analyzing the primary endpoint of NRG-HN004. NCT03258554-D1 contains baseline, treatment, and outcome data for the phase II extended follow-up analysis. NCT03258554-D2 contains all adverse events for the phase II extended follow-up analysis. NCT03258554-D4 contains data for the lead-in phase.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT03258554 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®